JHG-66240-95591
3 vaccinations
3 coded responses
6 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 05-11
- ZIP prefix
- 967 / HI
- Registered
- 2022-06-20
- Relationship
- Child or adolescent in my care
- Guardian
- 363-21082-00015
- Race
- Multiracial
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-11-06
Dose 1 — Pfizer-BioNTech
-
2021-12-02
Dose 2 — Pfizer-BioNTech
-
2022-05-28
Dose 3 — Pfizer-BioNTech
-
2022-06-20
Registered in v-safe
- 2022-06-25
-
2022-07-02
Survey response — day 35, dose 3, dependentMedDRA: Cough, Fatigue, Oropharyngeal pain, Pyrexia, Sneezing — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Fever, sore throat, fatigue, later cough & sneezingMedDRA releases: 2024-11 · check-in free text available
- 2022-07-09
- 2022-08-27
-
2022-11-28
Survey response — 6 months, dose 3, dependentMedDRA: Conjunctivitis, Nasopharyngitis, Pyrexia, SARS-CoV-2 test negative — Feeling: Good · Be unable to work or attend schoolFree text: Pink eye, severe cold symptoms a few weeks prior with fever but negative COVID test.MedDRA releases: 2024-11 · check-in free text available
-
2023-05-28
Survey response — 12 months, dose 3, dependentMedDRA: Cough, Gastrointestinal viral infection, Nasopharyngitis, Vomiting — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationMedDRA releases: 2024-11
-
2023-05-28
Call case (no matching report) — SuccessfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
-
2023-05-30
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-11-06 | Pfizer-BioNTech | No |
| 2 | 2021-12-02 | Pfizer-BioNTech | No |
| 3 | 2022-05-28 | Pfizer-BioNTech | No |
Call center
1 call center case
1 successful
Free text
Release 12 — day 35, dose 3, dependent
Symptoms: Fever, sore throat, fatigue, later cough & sneezing
Release 12 — 6 months, dose 3, dependent
Symptoms: Pink eye, severe cold symptoms a few weeks prior with fever but negative COVID test.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Conjunctivitis | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Gastrointestinal viral infection | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SD | Sneezing | · | · | ✓ |
| SD | Vomiting | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release